Evolus, Inc. (EOLS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Evolus, Inc.
Address
520 Newport Center Drive
Newport Beach, CA 92660
United States of America (the)
Phone
949 284 4555
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
353
First IPO Date
February 08, 2018
Key Executives
| Name | Title | Pay | Year Born |
| David Moatazedi | President, Chief Executive Officer & Director | 1.23M | 1978 |
| Tatjana Mitchell | Chief Financial Officer | 711,398 | N/A |
| Rui Avelar C.CFP Dip.SportMed | Chief Medical Officer and Head of Research & Development | 730,167 | 1962 |
| Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | 0 | N/A |
| Kurt Knab | Senior Vice President of Sales | 0 | N/A |
| Jeffrey J. Plumer | Corporate Secretary | 0 | N/A |
| Jessica Novak | Senior Vice President of Human Resources | 0 | N/A |
AD
Description
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
AD
